Insulin glargine: a systematic review of a long-acting insulin analogue.
about
Insulin degludec as an ultralong-acting basal insulin once a day: a systematic reviewThe Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential ImpactsInsulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectivesrDNA insulin glargine U300 - a critical appraisalThe investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes ManagementInsulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular diseaseDiabetes: glycaemic control in type 2 (drug treatments).Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring.Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats.Avoiding hypoglycaemia when treating type 1 diabetes.Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management.Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties - From an efficient E. coli expression system to a pharmaceutical formulation.Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of CarboCarrier® insulin.Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis.Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.Institution of basal-bolus therapy at diagnosis for children with type 1 diabetes mellitus.Basal insulin analogues in the management of diabetes mellitus: What progress have we made?Insulin biosimilars: the impact on rapid-acting analogue-based therapy.Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus.In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog.Controlled release of modified insulin glargine from novel biodegradable injectable gels.Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight.Changes in weight and BMI following the diagnosis of type 1 diabetes in children and adolescents.Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin.Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy.Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type 2 diabetes using continuous glucose monitoring system.Insulin glargine in pediatric patients with type 1 diabetes in Japan.Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].
P2860
Q24630395-22BB1737-8743-4BCE-A279-795D3C8ED11BQ26764842-C7377268-475F-467A-AF9F-47F0D5B4038FQ28074690-58E4B16C-4710-4969-9C0F-F9C9573B1F4EQ28077366-DB4AA895-3DCC-4CFE-A7F8-F9E1FA96243AQ33442343-F042F1DB-F200-4B42-AC8B-A7BE4A907B8CQ33621582-3E512B0B-B644-43B7-87C9-4691BF4F4932Q33769611-76F3FC3A-D8A9-487F-8FD8-836FCE6DD17CQ34829290-54BD3A5C-577F-4999-8218-78D021E28DE3Q35115119-0AB3FF9E-7E08-4E4C-98BD-1DDDC39062C2Q35609223-22B2E90C-F5DC-4A42-BCD3-7E83869FC4E1Q36211008-3EA043F5-E6C9-4212-86B8-C0FE974D4356Q36283816-57248EA0-E566-4ADC-AE5F-86995E37716DQ36308899-F9938022-C464-4826-8334-F100BFDCD627Q36321376-BCEB0B83-0E1C-42D2-B8AD-47BAF177C664Q36792962-3CA93B82-3ECE-4420-A190-9091546C71EFQ36989694-B73E9DF9-4C31-4CD1-A61A-625EC4F5A6DFQ37087031-F2739642-1D21-4D3D-8EF4-731C9F347A97Q37186391-923256B2-DCEE-4B94-B87E-0BC3696CBF46Q38136581-1D9D76CB-64A2-41AD-B34A-312CF1E22223Q38379020-3509E506-D544-4F4F-98A7-E60D619D90F0Q39054758-65A2AB90-FCA4-4C49-994B-F05B87DA8F13Q42491076-80527071-D645-45C5-9D6B-97230CF8AA59Q42588795-66FDBBBF-983E-4FC0-A1C3-D643BB9081E3Q43893344-3223C2C2-BE74-4953-B057-2CCA10252BBDQ44500493-C5123C07-9EE1-47DE-B424-4F2162676F71Q45740928-39B106FB-600B-43BE-933F-B1048B3F85BCQ46563558-B6EDDFB5-57C1-4CD1-9603-E31E8558EF4CQ46707992-B4EB5B23-520C-4E11-B715-6D285E6170E5Q46790310-C4E15B92-AA73-4E3E-B477-BA5CCCB0E232Q50568154-AB34EEDD-4C6D-4CC6-B18C-E7117BDED2A1Q51322375-B85AE40F-40AF-4869-9901-5846F8E90A97Q51375890-93D45881-5F68-4F3B-A9F5-F2F2A183FEB2Q52591845-95AC21F2-2298-4093-8F11-AE89711D1EE8Q52836101-88DE6A57-3053-40B7-916A-3BF0E66FB8C1
P2860
Insulin glargine: a systematic review of a long-acting insulin analogue.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Insulin glargine: a systematic review of a long-acting insulin analogue.
@ast
Insulin glargine: a systematic review of a long-acting insulin analogue.
@en
type
label
Insulin glargine: a systematic review of a long-acting insulin analogue.
@ast
Insulin glargine: a systematic review of a long-acting insulin analogue.
@en
prefLabel
Insulin glargine: a systematic review of a long-acting insulin analogue.
@ast
Insulin glargine: a systematic review of a long-acting insulin analogue.
@en
P2093
P1476
Insulin glargine: a systematic review of a long-acting insulin analogue.
@en
P2093
Cunegundo M Vergara
Jana M Carabino
P304
1541-77, discussion 1539-40
P356
10.1016/S0149-2918(03)80156-X
P577
2003-06-01T00:00:00Z